Delivery Order SPE2DB24D1205-SPE2DB25FCUSC
Award Date
3/7/25
Potential Completion Date
3/10/25
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp is for the supply of Briviact 10 mg/ml oral solution (300 ml) to the Defense Logistics Agency (DLA), a defense agency. The firm-fixed-price delivery order has a ceiling value of $4,975.74 and a completion date of September 26, 2023. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Briviact 10 mg/ml oral solution (300 ml). The $2,558.34 firm fixed price contract has a period of performance through November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a broad range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $2,558.34 Firm Fixed Price delivery order is for the supply of Briviact 10 mg/ml oral solution in 300 ml bottles. This order is not associated with a set-aside program and has an ultimate completion date of August 12, 2024. Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide 60 tablets of the medication Briviact 50 mg. The firm-fixed-price delivery order is valued at $4,964.40 and has a completion date of March 24, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Briviact 25 mg tablets. The contract, valued at $2,484.06, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award, valued at $1,140.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Briviact 10 mg/mL oral solution. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with an ultimate completion date of September 20, 2024. This award does not have a set-aside designation. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $5,107.02, is a firm fixed price delivery order for the supply of the pharmaceutical product Briviact 50 mg tablets. The contract has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Briviact (10 mg/ml oral solution, 300 ml) to support Department of Defense healthcare requirements. The Ceiling Value of this Firm Fixed Price Delivery Order is $1,704.12, with a completion date of July 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a value of $2,239.43, is for the procurement of the drug Briviact 50 mg tablets. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of January 7, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,557.92 firm fixed-price contract is for the delivery of Briviact 100 mg tablets to support federal healthcare programs. The contract has an ultimate completion date of October 18, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...